MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ECOR — electroCore, Inc. Common Stock
NasdaqelectroCore, Inc. Common Stock
$10.14
-0.18(-1.70%)
- O
- 10.47
- H
- 11.02
- L
- 9.92
- V
- 122.16K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ECOR
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
SectorNot available
IPO DateJun 22, 2018
Employees83
Stock ExchangeNasdaq
Ticker SymbolECOR
Websitehttps://www.electrocore.com
Key Financial Statistics
| Market Cap | $91.42M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $4.41 - $12.70 |
| 52-Week Avg Volume | 80.0K |
| VWAP | $10.31 |
| Transactions | 1,027 |
| Total Recorded Bars | 2,081 days |